Blood Pressure Management in Acute Ischemic Stroke

Blood Pressure Targets

• The American College of Cardiology recommends using SBP targets for patients receiving reperfusion therapy and considering MAP reduction (by 15%) only for patients with extremely elevated blood pressure (>220/120 mmHg) who are not receiving reperfusion therapy 1, 2, 3
• For patients receiving reperfusion therapy, the American College of Cardiology suggests lowering SBP to <185 mmHg and DBP <110 mmHg before initiating IV thrombolysis, and maintaining SBP <180 mmHg and DBP <105 mmHg for at least the first 24 hours 1, 2, 3, 4
• The European Heart Journal recommends a MAP reduction target of 15% during the first 24 hours for patients with BP ≥220/120 mmHg who are not receiving reperfusion therapy 2, 3

Rationale for Different Approaches

• The American College of Cardiology states that cerebral autoregulation is impaired in the ischemic penumbra, and systemic perfusion pressure is needed for blood flow and oxygen delivery 1, 3
• The European Heart Journal notes that higher BP increases risk of hemorrhagic transformation after reperfusion, and more precise control is needed to balance reperfusion benefits against bleeding risks 2, 3

Timing of BP Management

• The American College of Cardiology recommends a conservative approach for patients not receiving reperfusion therapy during the first 48-72 hours, and a more aggressive approach for patients receiving reperfusion therapy 1, 2, 3, 4
• The European Heart Journal suggests initiating or reintroducing BP-lowering medication for stable patients who remain hypertensive (≥140/90 mmHg) after 3 days 4, 5

Pharmacological Considerations

• The European Heart Journal recommends labetalol as the preferred agent for BP control in acute ischemic stroke, and nicardipine as an effective alternative 2, 3
• The European Heart Journal advises avoiding sodium nitroprusside due to its adverse effects on cerebral autoregulation and intracranial pressure 2, 3

Common Pitfalls to Avoid

• The American College of Cardiology warns against lowering BP too aggressively in patients not receiving reperfusion therapy, which can compromise cerebral perfusion 1, 3
• The European Heart Journal cautions against treating BP <220/120 mmHg in the first 48-72 hours in patients not receiving thrombolysis, and failing to monitor BP frequently during the first 24 hours 1, 3, 6

Special Considerations

• The Stroke journal notes that both hypertension and hypotension are associated with poor outcomes in acute ischemic stroke, and patients are often volume depleted due to pressure natriuresis 7, 2

Risks of Sudden Blood Pressure Regulation in Stroke

Mechanism of Harm

• Cerebral perfusion becomes pressure-dependent when autoregulation fails in the ischemic zone, meaning that systemic blood pressure is needed for oxygen delivery and blood flow to potentially salvageable brain tissue, according to the American Heart Association 8
• Rapid BP reduction can extend the infarct by reducing perfusion pressure to the penumbra, converting potentially salvageable tissue into irreversibly damaged brain, as stated by the American Stroke Association 9
• Even lowering BP to levels within the hypertensive range can be detrimental if done too quickly, as the ischemic brain cannot compensate for sudden pressure changes, as noted by the American Heart Association 8

Specific Documented Complications

• Cerebral infarction from inadequate perfusion pressure can occur when blood pressure is lowered too rapidly or aggressively, according to the American Stroke Association 10
• Worsening neurological symptoms and increased stroke severity can result from rapid BP reduction, as reported by the American Stroke Association 9
• Angina and ischemic ECG changes can occur due to decreased perfusion pressure, as noted by the American Stroke Association 10

Critical Thresholds and Safe Practices

• The American Heart Association recommends not treating BP unless systolic >220 mmHg or diastolic >120 mmHg during the first 48-72 hours, as permissive hypertension may enhance collateral flow to ischemic tissue 11
• If treatment is required, the American Stroke Association suggests reducing mean arterial pressure by only 15% over 24 hours, not more aggressively, to avoid compromising cerebral perfusion 11
• BP must be <185/110 mmHg before initiating rtPA and maintained <180/105 mmHg for at least 24 hours afterward to prevent hemorrhagic transformation, as recommended by the American Heart Association 8

Agents to Avoid

• Sublingual nifedipine and other agents causing precipitous BP reductions should be avoided, as they cannot be titrated and may cause dangerous rapid drops in cerebral perfusion, according to the American Stroke Association 11

The U-Shaped Relationship

• Optimal admission BP ranges from 121-200 mmHg systolic and 81-110 mmHg diastolic based on observational data showing a U-shaped mortality curve, as reported by the American Heart Association 8

Common Pitfalls

• Treating elevated BP reflexively without considering that it may represent a compensatory response to maintain cerebral perfusion can be harmful, as noted by the American Stroke Association 12 and the American Heart Association 9

Blood Pressure Management in Acute Ischemic Stroke

Optimal Blood Pressure Targets

• The American Heart Association recommends maintaining systolic blood pressure between 121-200 mmHg (corresponding to mean arterial pressure approximately 90-140 mmHg) for optimal outcomes in patients with acute ischemic stroke not receiving reperfusion therapy 13
• For patients receiving IV thrombolysis, the American Heart Association recommends lowering blood pressure to <185/110 mmHg (mean arterial pressure <135 mmHg) before thrombolysis, and maintaining blood pressure <180/105 mmHg (mean arterial pressure <130 mmHg) for at least 24 hours 14
• For patients receiving mechanical thrombectomy, the American Heart Association recommends maintaining blood pressure <185/110 mmHg (mean arterial pressure <135 mmHg) before the procedure, and maintaining systolic blood pressure <180 mmHg (mean arterial pressure approximately <120-130 mmHg) after the procedure 14

Secondary Prevention

• The American Stroke Association recommends initiating or restarting antihypertensive medications in neurologically stable patients with blood pressure ≥140/90 mmHg after 3 days, with a target blood pressure <130/80 mmHg for long-term secondary prevention 15

Pharmacological Agents for Hypertension Control

• The American Heart Association recommends using labetalol, nicardipine, or clevidipine as preferred agents for blood pressure lowering in patients with acute ischemic stroke, with specific dosing regimens for each agent 14

Critical Pitfalls to Avoid

• Rapid blood pressure reduction can extend infarct size by reducing perfusion to the penumbra, and studies show that decreases in blood pressure during acute stroke are associated with poor outcomes 13
• A U-shaped relationship exists between blood pressure and outcomes, with both extremes being harmful, and overly aggressive blood pressure lowering is dangerous 13

Blood Pressure Measurement in Stroke Patients

Clinical Implications for Blood Pressure Monitoring

• The American Heart Association recommends that blood pressure must be precisely controlled to <185/110 mmHg before thrombolytic therapy and maintained <180/105 mmHg for at least 24 hours afterward in patients eligible for thrombolytic therapy 16, 17
• Using the affected limb for blood pressure measurement could result in underestimating true systemic pressure, leading to inappropriate administration of thrombolytics with increased risk of hemorrhagic transformation 16
• The consensus threshold for treating blood pressure in acute ischemic stroke (not receiving thrombolysis) is systolic >220 mmHg or diastolic >120 mmHg, according to the American Stroke Association 16, 17, 18
• Falsely low readings from the affected limb could mask dangerously elevated blood pressure that requires urgent treatment to prevent complications such as hemorrhagic transformation, brain edema, or further vascular damage 16

Practical Recommendations

• The International Stroke Society recommends documenting which limb is being used for blood pressure monitoring and maintaining consistency throughout the acute phase 18
• For patients receiving thrombolysis, the American Heart Association recommends monitoring blood pressure every 15 minutes for 2 hours, every 30 minutes for 6 hours, then hourly for 16 hours 16, 17
• For patients not receiving thrombolysis, the International Stroke Society recommends routine vital sign monitoring with particular attention during the first 24-48 hours when blood pressure is most labile 18

Blood Pressure Management in Acute Ischemic Stroke

Treatment Algorithm Based on Reperfusion Status

• The American Heart Association recommends maintaining permissive hypertension, avoiding treatment of blood pressure below 220/120 mmHg, for the first 48-72 hours unless the patient receives thrombolysis or thrombectomy, in which case blood pressure should be lowered to below 185/110 mmHg before treatment and maintained below 180/105 mmHg for 24 hours afterward, to minimize hemorrhagic transformation risk 19
• High blood pressure during the initial 24 hours after thrombolysis significantly increases the risk of symptomatic intracranial hemorrhage, highlighting the need for careful blood pressure management in patients receiving reperfusion therapy 19

Critical Timing Considerations

• The American College of Cardiology recommends initiating or restarting antihypertensive therapy in neurologically stable patients with blood pressure above 140/90 mmHg after 72 hours, with a target blood pressure of below 130/80 mmHg for long-term secondary prevention, using preferred agents such as thiazide diuretics, ACE inhibitors, ARBs, or combination therapy 19

Special Circumstances Requiring Immediate BP Control

• The American Heart Association recommends overriding permissive hypertension guidelines in cases of hypertensive encephalopathy, requiring immediate blood pressure control to prevent further complications 19

Blood Pressure Management in Acute Ischemic Stroke

Primary Considerations

• The European Society of Cardiology recommends not treating blood pressure unless it exceeds 220/120 mmHg during the first 48-72 hours in patients not receiving reperfusion therapy, and if BP exceeds 220/120 mmHg, reduce mean arterial pressure by only 15% over 24 hours 20
• The American Heart Association recommends that blood pressure MUST be <185/110 mmHg before initiating rtPA and maintained <180/105 mmHg for at least 24 hours afterward in patients receiving IV thrombolysis 21, 20, 22

Management Algorithms

• For patients receiving mechanical thrombectomy, the European Society of Cardiology recommends maintaining BP <180/105 mmHg before and for 24 hours after the procedure 20
• The American Heart Association recommends monitoring BP every 15 minutes for 2 hours, every 30 minutes for 6 hours, then hourly for 16 hours in patients receiving IV thrombolysis 21, 22

Pharmacological Agents

• The American Heart Association recommends labetalol as a first-line agent, 10-20 mg IV over 1-2 minutes, may repeat; or continuous infusion 2-8 mg/min, due to ease of titration and minimal cerebral vasodilatory effects 21, 22
• The American Heart Association recommends nicardipine as an effective alternative, 5 mg/h IV, titrate by 2.5 mg/h every 5-15 minutes, maximum 15 mg/h, especially with bradycardia or heart failure 21, 22
• The American Heart Association recommends avoiding sublingual nifedipine as it cannot be titrated and causes precipitous BP drops that may compromise cerebral perfusion 23
• The European Society of Cardiology recommends avoiding sodium nitroprusside due to adverse effects on cerebral autoregulation and intracranial pressure, reserving it only for refractory hypertension 20

Special Circumstances

• The American Heart Association recommends immediate BP control regardless of stroke guidelines in cases of hypertensive encephalopathy, aortic dissection, acute myocardial infarction, acute pulmonary edema, or acute renal failure 23

Long-Term Secondary Prevention

• The European Society of Cardiology recommends initiating or restarting antihypertensives targeting <130/80 mmHg for secondary prevention in neurologically stable patients with BP ≥140/90 mmHg after 3 days 20

Permissive Hypertension Duration in Acute Ischemic Stroke

Blood Pressure Management Algorithm

• The American College of Cardiology recommends that permissive hypertension should be maintained for 48-72 hours after acute ischemic stroke in patients who do not receive thrombolytic therapy or endovascular treatment and have blood pressure <220/120 mmHg 24, 25, 26, 27
• For patients not receiving reperfusion therapy, the American College of Cardiology suggests not treating blood pressure if <220/120 mmHg, as initiating or reinitiating antihypertensive treatment during this window is ineffective to prevent death or dependency (Class III: No Benefit) 24, 25, 27
• If blood pressure is ≥220/120 mmHg, consider lowering mean arterial pressure by only 15% during the first 24 hours after stroke onset, as recommended by the American College of Cardiology and Hypertension guidelines 24, 25, 26
• After 48-72 hours, initiate or restart antihypertensive medications in neurologically stable patients with BP ≥140/90 mmHg for long-term secondary prevention, according to the Hypertension and American College of Cardiology guidelines 26, 27

Blood Pressure Targets for Patients Receiving IV Thrombolysis

• Before thrombolysis, lower blood pressure to <185/110 mmHg, as recommended by the American College of Cardiology and Hypertension guidelines 24, 26, 27
• After thrombolysis, maintain blood pressure <180/105 mmHg for at least the first 24 hours, according to the American College of Cardiology and Hypertension guidelines 24, 26, 27
• High blood pressure during the initial 24 hours after thrombolysis significantly increases the risk of symptomatic intracranial hemorrhage, as noted by the American College of Cardiology 27

Physiologic Rationale

• Cerebral autoregulation is grossly abnormal in the ischemic penumbra, and systemic perfusion pressure is needed for blood flow and oxygen delivery to potentially salvageable brain tissue, as explained by the American College of Cardiology and Hypertension guidelines 24, 25, 26
• Studies demonstrate a U-shaped relationship between admission blood pressure and outcomes, with optimal systolic blood pressure ranging from 121-200 mmHg, according to the American College of Cardiology and Hypertension guidelines 24, 25, 26

Permissive Hypertension in Acute Ischemic Stroke

Blood Pressure Management

• The American Heart Association recommends lowering blood pressure to <185/110 mmHg before initiating thrombolysis, and maintaining blood pressure <180/105 mmHg for at least 24 hours after thrombolysis, to reduce the risk of symptomatic intracranial hemorrhage 28
• The American Heart Association suggests monitoring blood pressure every 15 minutes for 2 hours from the start of rtPA, every 30 minutes for 6 hours, and every hour for 16 hours, to ensure blood pressure control 28
• The American Heart Association recommends labetalol as a first-line agent for blood pressure control, with a dose of 10-20 mg IV over 1-2 minutes, or a continuous infusion of 2-8 mg/min, due to its ease of titration and minimal cerebral vasodilatory effects 28
• The American Heart Association recommends nicardipine as an effective alternative to labetalol, with a dose of 5 mg/h IV, titrated by 2.5 mg/h every 5-15 minutes, for blood pressure control 28
• It is reasonable to temporarily discontinue or reduce premorbid antihypertensive medications before 48-72 hours, as swallowing is often impaired and responses may be less predictable during acute stress, according to the American Heart Association 28
• Failing to recognize hypotension, which is associated with poor outcomes, requires urgent evaluation and correction, as stated by the American Heart Association 28

Target Mean Arterial Pressure in Acute Ischemic Stroke

Blood Pressure Management

• The European Society of Cardiology recommends maintaining permissive hypertension without active BP lowering for 48-72 hours in acute ischemic stroke patients not receiving reperfusion therapy with BP <220/120 mmHg 29, 30
• For patients receiving thrombolysis or thrombectomy, the European Society of Cardiology recommends lowering BP to <185/110 mmHg (MAP <135 mmHg) before treatment and maintaining <180/105 mmHg (MAP <130 mmHg) for at least 24 hours afterward 29, 30
• The American College of Cardiology is not mentioned, however the European Society of Cardiology suggests that if BP ≥220/120 mmHg, reduce MAP by only 15% over the first 24 hours, which translates to lowering MAP from approximately 153 mmHg to 130 mmHg 29, 30

Special Circumstances

• In cases of hypertensive encephalopathy, override permissive hypertension guidelines and control BP immediately, as recommended by the European Society of Cardiology 29
• In cases of acute pulmonary edema, override permissive hypertension guidelines and control BP immediately, as recommended by the American Heart Association 31

Critical Care Considerations

• For patients on ECMO with concurrent acute ischemic stroke, maintain MAP >70 mmHg and individualize BP goals based on comorbidities and cerebral autoregulation status, as recommended by the Critical Care society 32

Pharmacological Agents

• Labetalol is a preferred agent for acute BP control, with advantages including easy titration and minimal cerebral vasodilatory effects, as recommended by the American Heart Association 31
• Nicardipine is an effective alternative, particularly useful with bradycardia or heart failure, as recommended by the American Heart Association 31

Blood Pressure Management in Acute Stroke

Clinical Guidelines

• The European Society of Cardiology recommends not treating blood pressure unless it exceeds 220/120 mmHg in patients not receiving reperfusion therapy, as lowering blood pressure in this range has not been shown to prevent death or dependency and may worsen outcomes by compromising cerebral perfusion to the ischemic penumbra 33
• The European Society of Cardiology suggests that if a patient received or is receiving thrombolysis/thrombectomy, blood pressure must be <185/110 mmHg before treatment and maintained <180/105 mmHg for at least 24 hours afterward to minimize hemorrhagic transformation risk 33
• The European Society of Cardiology advises against automatically restarting home antihypertensives during the first 48-72 hours unless there are specific comorbid conditions requiring blood pressure control, and recommends avoiding sublingual nifedipine as it cannot be titrated and causes precipitous blood pressure drops that may compromise cerebral perfusion 33
• The European Society of Cardiology recommends reducing mean arterial pressure by only 15% over 24 hours if blood pressure reaches 220/120 mmHg during the permissive window, and suggests using IV labetalol or IV nicardipine as first-line agents 33
• The European Society of Cardiology states that immediate blood pressure control is required regardless of stroke timing if the patient has hypertensive encephalopathy, acute aortic dissection, acute pulmonary edema, or acute renal failure, and recommends treating blood pressure aggressively per the specific condition's requirements rather than following stroke-specific guidelines 33

Management of Blood Pressure in Acute Ischemic Stroke

Physiologic Rationale

• The brain attempts to compensate for impaired cerebral autoregulation through dilation of leptomeningeal collaterals, but this mechanism depends on adequate systemic pressure to maintain flow, as noted by the American Heart Association 34

Critical Care Management

• In exceptional cases with systemic hypotension producing neurological sequelae, vasopressors may be prescribed to improve cerebral blood flow, with close neurological and cardiac monitoring, according to the American Stroke Association 35

Special Circumstances

• Immediate blood pressure control is required regardless of stroke guidelines in cases of acute myocardial infarction, as recommended by the American Heart Association 35

Blood Pressure Management in Acute Ischemic Stroke with Admission Systolic ≈ 170 mmHg

Initial Management (First 48–72 h)

• Hold all chronic antihypertensive agents for the first 48–72 hours in patients with acute ischemic stroke and a systolic BP of ~170 mmHg, unless thrombolysis or endovascular therapy is planned. (ACC/AHA 2017 guideline, Class III – No Benefit) 36, 37, 38
• Do not initiate antihypertensive treatment during this window when no reperfusion therapy is given; initiating or re‑initiating drugs in patients with BP < 220/120 mmHg does not reduce death or dependency. (ACC/AHA 2017 guideline, Class III – No Benefit) 36, 37, 38
• A systolic BP of 170 mmHg lies within the observationally‑derived optimal range (121–200 mmHg) that shows a U‑shaped relationship with outcomes. (Observational cohort data) 36

Patients Undergoing Thrombolysis or Endovascular Therapy

• Blood pressure must be lowered to <185/110 mmHg before initiating IV thrombolysis and kept <180/105 mmHg for at least the first 24 hours after treatment. (ACC/AHA 2017 guideline, Class I) 36, 37, 38
• Elevated BP during the first 24 hours after thrombolysis markedly raises the risk of symptomatic intracranial hemorrhage. (Observational studies) 36, 37

Post‑Acute Phase (After 48–72 h)

• Restart antihypertensive therapy after 48–72 hours if the patient is neurologically stable and systolic/diastolic BP remains ≥140/90 mmHg. (ACC/AHA 2017 guideline, Class IIa – Reasonable) 36, 37, 38
• ACC/AHA guidelines provide Class I evidence that patients with previously treated hypertension should have antihypertensives re‑started after the first few days to lower the risk of recurrent stroke and other vascular events. 36, 37
• For long‑term secondary prevention, aim for a target BP < 130/80 mmHg using thiazide diuretics, ACE inhibitors, ARBs, or combination therapy. (Guideline recommendation) 36, 39

Critical Exceptions Requiring Immediate BP Control

• Hypertensive encephalopathy mandates urgent BP reduction despite permissive‑hypertension recommendations. (ACC/AHA 2017 guideline) 36

Evidence‑Based Pitfalls and Safety Limits

• A randomized controlled trial found no benefit to continuing prestroke antihypertensive drugs during the first few days after an acute stroke. (RCT) 36
• If BP exceeds 220/120 mmHg and treatment is required, reduce mean arterial pressure by no more than 15 % over the first 24 hours. (Guideline safety limit) 36
• Hypotension in the acute stroke setting can be more detrimental than hypertension and should be promptly identified and corrected. (Observational data) 36

Blood Pressure Targets in Acute Ischemic Stroke

Patients Not Receiving Reperfusion Therapy

Patients Receiving Intravenous Thrombolysis (rtPA)

Timing of Antihypertensive Resumption

Long‑Term Secondary Prevention

Guideline Recommendations for Initiating Antihypertensive Therapy One Week After Stroke

Timing and Rationale

• Initiating antihypertensive therapy in neurologically stable patients one week after an ischemic stroke is strongly recommended to reduce recurrent stroke risk and improve long‑term outcomes when systolic/diastolic BP is ≥140/90 mmHg. Class I recommendation. 41
• The acute “permissive hypertension” window (first 48–72 h) has ended; during that period elevated BP supports cerebral perfusion to the ischemic penumbra where autoregulation is impaired. 42
• After the first three days, management shifts from acute neuroprotection to secondary stroke prevention; the ACC/AHA guidelines assign a Class IIa recommendation for starting or restarting antihypertensives in stable patients with BP > 140/90 mmHg during hospitalization. 41
• In patients with a prior history of hypertension, restarting therapy after the early phase carries a Class I recommendation (strongest evidence) to lower the risk of recurrent stroke and other vascular events. 42

Blood Pressure Targets for Secondary Prevention

• The target for long‑term secondary prevention in stroke/TIA survivors is <130/80 mmHg; this target is supported by Class IIb evidence. 41
• For lacunar stroke subtypes, a systolic target <130 mmHg also carries Class IIb evidence. 42

First‑Line Antihypertensive Medication Classes

• Thiazide diuretics, ACE inhibitors, and angiotensin‑receptor blockers (ARBs) are all designated Class I agents for secondary stroke prevention. 41
• All first‑line classes are considered useful and effective with Class I evidence. 41
• Choice of agent should be individualized based on comorbidities (e.g., ACE inhibitors/ARBs preferred in patients with diabetes and albuminuria; beta‑blockers avoided in bradycardic patients). 42

Monitoring and Safety

• Antihypertensive therapy should only be started after confirming neurological stability; any ongoing neurological deterioration mandates holding antihypertensives. Class IIa recommendation. 41
• Blood pressure should be measured at every clinical encounter and at least monthly until the target is achieved, with gradual titration over weeks to months rather than rapid reduction.

Special Considerations

• Previously treated hypertensive patients: Restarting therapy (Class I) can reduce recurrent stroke risk by up to ~43 % when appropriate combinations are used. 42
• Previously untreated patients: Evidence for initiating therapy when BP is <140/90 mmHg is less robust (Class I but “usefulness not well established”); however, initiating treatment at a BP of 136/81 mmHg is still reasonable if trends suggest upward drift. 41

All statements are derived from guideline societies (e.g., ACC/AHA) and reflect the strength of evidence as indicated.

Blood Pressure Management in Acute Ischemic Stroke

Initial Assessment for Thrombolysis Eligibility

• Determine the exact time of symptom onset (last known normal) to assess eligibility for intravenous thrombolysis in patients presenting with acute unilateral weakness. 43

Patients Not Receiving Reperfusion Therapy (No Thrombolysis or Thrombectomy)

• Permissive Hypertension Strategy – In adults with acute ischemic stroke who are not candidates for reperfusion therapy, maintain systolic/diastolic blood pressure below 220/120 mm Hg for the first 48–72 hours; do not initiate antihypertensive treatment unless this threshold is exceeded. This approach is supported by the American Heart Association/American Stroke Association (AHA/ASA) recommendations. [44][43]

• Physiologic Rationale – Cerebral autoregulation is impaired in the ischemic penumbra, making cerebral perfusion directly dependent on systemic pressure; lowering BP below 220/120 mm Hg has not been shown to reduce mortality or dependency and may worsen outcomes by compromising collateral flow. 44

• Management When BP ≥ 220/120 mm Hg – Reduce mean arterial pressure by only ~15 % over the first 24 hours using intravenous labetalol (10–20 mg bolus, repeat every 10 min as needed) or nicardipine (initial 5 mg/h, titrate by 2.5 mg/h every 15 min, max 15 mg/h). This modest reduction avoids jeopardizing penumbral perfusion. 44

• Avoid Rapid Drops – Systolic reductions > 70 mm Hg can precipitate cerebral, renal, or coronary ischemia and should be avoided. 43

Patients Receiving Intravenous Thrombolysis (rtPA)

• Pre‑Thrombolysis Blood Pressure Target – Blood pressure must be lowered to < 185/110 mm Hg before initiating rtPA to minimize the risk of hemorrhagic transformation. Intravenous labetalol or nicardipine are the preferred agents. 44

• Contraindication for Uncontrolled Hypertension – If blood pressure cannot be reduced below 185/110 mm Hg despite appropriate therapy, intravenous thrombolysis should be withheld. 44

• Post‑Thrombolysis Blood Pressure Management – Maintain blood pressure < 180/105 mm Hg for at least the first 24 hours after rtPA administration, with frequent monitoring (every 15 min for 2 h, then every 30 min for 6 h, then hourly). This range reduces the incidence of symptomatic intracranial hemorrhage. [44][43]

• Preferred Intravenous Antihypertensives –

  • Labetalol: 10–20 mg IV bolus over 1–2 min; repeat or double every 10 min (max cumulative 300 mg) or continuous infusion 2–8 mg/min.
  • Nicardipine: start at 5 mg/h IV, titrate by 2.5 mg/h every 15 min, max 15 mg/h.

• Avoid Sublingual Nifedipine – This formulation can cause unpredictable, precipitous blood pressure declines that may compromise cerebral perfusion.

Optimal Blood Pressure Range When No Reperfusion Therapy Is Planned

• A systolic/diastolic range of approximately 150–180 mm Hg / 90–110 mm Hg is considered optimal for supporting collateral circulation in acute ischemic stroke patients not undergoing reperfusion; active treatment to lower pressure within this range is not recommended. 44

Long‑Term Secondary Stroke Prevention (Beyond the Acute Phase)

• After the first 72 hours, target a blood pressure < 130/80 mm Hg for secondary prevention using agents such as thiazide diuretics, ACE inhibitors, or ARBs (guideline‑based recommendation, no specific citation in the source).

Target Mean Arterial Pressure in Acute Ischemic Stroke

1. Patients Not Receiving Reperfusion Therapy (Thrombolysis or Thrombectomy)

• Permissive hypertension – Do not start or restart antihypertensive drugs when systolic blood pressure is < 220 mm Hg or diastolic < 120 mm Hg (corresponding to MAP < 153 mm Hg) during the first 48–72 hours after stroke onset. 45, 46
• When MAP ≥ 153 mm Hg – Reduce MAP by only ≈ 15 % over the first 24 hours (e.g., from ~153 mm Hg to ~130 mm Hg) to avoid worsening cerebral perfusion. 45, 46
• Physiologic rationale – In the ischemic penumbra, cerebral autoregulation is impaired, so cerebral blood flow becomes directly dependent on systemic blood pressure; aggressive lowering may enlarge the infarct. 45
• Preferred pharmacologic agents for controlled reduction – Intravenous labetalol (10–20 mg bolus, repeatable) or nicardipine (starting 5 mg/h, titrated by 2.5 mg/h every 5–15 min, max 15 mg/h). 45

2. Patients Receiving Intravenous Thrombolysis (rtPA)

• Pre‑thrombolysis BP target – Blood pressure must be < 185/110 mm Hg (MAP < 135 mm Hg) before initiating rtPA; if this cannot be achieved, thrombolysis should be withheld. 45, 46
• Post‑thrombolysis BP target – Maintain < 180/105 mm Hg (MAP < 130 mm Hg) for at least the first 24 hours after rtPA to reduce the risk of symptomatic intracranial hemorrhage. 45, 46
• Monitoring schedule – Measure blood pressure every 15 minutes for the first 2 hours, every 30 minutes for the next 6 hours, then hourly for the remaining 16 hours. 45
• Preferred antihypertensive agents –
  
  • Labetalol: 10–20 mg IV bolus (repeatable) or continuous infusion 2–8 mg/min (easy titration, minimal cerebral vasodilation). 45
  • Nicardipine: 5 mg/h IV, titrated by 2.5 mg/h every 5–15 minutes, max 15 mg/h (effective alternative, especially with bradycardia or heart failure). 45
  • Clevidipine: 1–2 mg/h IV, dose doubled every 2–5 minutes, max 21 mg/h (rapid titratable option). 45

3. Post‑Acute Phase (After 48–72 Hours)

• Restart antihypertensive therapy – In neurologically stable patients with blood pressure ≥ 140/90 mm Hg, antihypertensive medications should be re‑initiated. 45

4. Urgent Situations Requiring Immediate Blood Pressure Control (Override Permissive Hypertension)

• Conditions – Hypertensive encephalopathy, acute aortic dissection, acute myocardial infarction, and acute pulmonary edema all mandate prompt blood‑pressure lowering irrespective of the permissive‑hypertension strategy. 45

5. Contraindicated or Cautious Pharmacologic Practices

• Sodium nitroprusside – Should not be used routinely for blood‑pressure control in acute ischemic stroke; reserve only for refractory hypertension. 45

6. Management of Hypotension

• Immediate correction – Prompt treatment of hypotension is essential because low blood pressure is associated with poor neurological outcomes. 45, 46

Blood Pressure Management in Acute Ischemic Stroke – Patients Not Receiving Reperfusion Therapy

Initial 48–72 Hour Permissive Hypertension Phase

• Do not initiate or restart antihypertensive medication when systolic < 220 mmHg or diastolic < 120 mmHg (MAP < 153 mmHg).

Management of Severe Hypertension (MAP ≥ 153 mmHg / BP ≥ 220/120 mmHg)

• If MAP reaches ≥ 153 mmHg, lower MAP by only ≈ 15 % over the first 24 hours (e.g., from ~153 mmHg to ~130 mmHg).

Transition to Secondary Prevention (After 48–72 Hours)

• Restart antihypertensive therapy in neurologically stable patients when BP ≥ 140/90 mmHg (MAP ≥ 93 mmHg).

Critical Exceptions Requiring Immediate Blood‑Pressure Control

• Override the permissive‑hypertension approach and treat blood pressure immediately in any of the following acute conditions, regardless of the 48–72 hour window:

Evidence Quality and Nuances

• Permissive‑hypertension strategy (no treatment below 220/120 mmHg) is supported by Class III (No Benefit) evidence from two randomized controlled trials and systematic reviews/meta‑analyses that found no benefit—and potential harm—from lowering blood pressure below this threshold during the acute phase. 47, 48

• The 15 % MAP‑reduction threshold for extreme hypertension is based on Class IIb (uncertain benefit) evidence and expert consensus, reflecting a balance between preventing hypertensive complications and maintaining cerebral perfusion. 47

Permissive Hypertension Management in Acute Ischemic Stroke

Blood‑Pressure Management – Patients Not Receiving Reperfusion Therapy

• Do not start or restart antihypertensive drugs during the first 48–72 h when systolic < 220 mmHg or diastolic < 120 mmHg (MAP < 153 mmHg); lowering blood pressure in this range does not reduce death or dependency and may worsen outcomes by compromising perfusion to the ischemic penumbra. – Class III (No Benefit), American College of Cardiology 49

• If blood pressure rises to ≥220/120 mmHg during the permissive window, reduce mean arterial pressure by ≈15 % over the first 24 h (e.g., from ~153 mmHg to ~130 mmHg) using intravenous labetalol (10–20 mg bolus, repeatable every 10 min) or nicardipine (starting 5 mg/h, titrated by 2.5 mg/h every 15 min, max 15 mg/h). – Recommendation based on American College of Cardiology evidence 49

• After the 48–72 h period, restart antihypertensive therapy in neurologically stable patients when blood pressure is ≥140/90 mmHg for long‑term secondary stroke prevention. – Class IIa, American College of Cardiology 49

• Aim for a target blood pressure <130/80 mmHg using thiazide diuretics, ACE inhibitors, ARBs, or combination therapy for secondary prevention. – American College of Cardiology guidance 49

Blood‑Pressure Management – Patients Receiving Intravenous Thrombolysis (tPA)

• Before tPA administration, blood pressure must be lowered to <185/110 mmHg (MAP < 135 mmHg). – Class I, American College of Cardiology 49

• After tPA, maintain blood pressure <180/105 mmHg (MAP < 130 mmHg) for at least the first 24 h to minimize the risk of symptomatic intracranial hemorrhage. – Class I, American College of Cardiology 49

Physiologic Rationale

• Cerebral autoregulation is markedly impaired in the ischemic penumbra, making cerebral blood flow directly dependent on systemic perfusion pressure; rapid blood‑pressure reduction can enlarge the infarct by depriving salvageable tissue of adequate flow. – American College of Cardiology evidence 49

Critical Exceptions Requiring Immediate Blood‑Pressure Control

• In the presence of hypertensive encephalopathy, acute myocardial infarction, or acute pulmonary edema, the permissive‑hypertension strategy must be abandoned and blood pressure should be lowered aggressively according to the specific condition’s protocol. – American College of Cardiology recommendation 49

Evidence Summary

• Two randomized controlled trials and multiple systematic reviews/meta‑analyses show that antihypertensive agents effectively lower blood pressure during the acute phase but do not improve short‑ or long‑term dependency or mortality; this underpins the Class III (No Benefit) rating for initiating or re‑initiating therapy within the first 48–72 h. – Class III, American College of Cardiology 49

• One randomized trial demonstrated no benefit to continuing pre‑stroke antihypertensive medications during the initial days after an acute stroke. – Class III, American College of Cardiology 49

Permissive Hypertension and Blood‑Pressure Management in Acute Ischemic Stroke

Diagnostic Priorities

• Determining the exact “last known well” time is required to assess eligibility for intravenous alteplase, which must be administered within 4.5 hours of symptom onset (American Heart Association/American Stroke Association). 50

Critical Initial Assessment

• The National Institutes of Health Stroke Scale (NIHSS) should be performed on arrival to quantify stroke severity and provide a baseline for monitoring (American Heart Association/American Stroke Association). 51
• An emergent non‑contrast head CT must be obtained within 25 minutes of presentation to exclude intracerebral hemorrhage and to identify early ischemic changes (American College of Cardiology/American Heart Association). 52
• Blood pressure should be measured in both arms (and, if needed, in both legs) to detect pressure differentials that may indicate an aortic dissection, a potential stroke mimic (American College of Cardiology/American Heart Association). 53
• Immediate laboratory studies—including serum glucose, complete blood count, coagulation profile (INR, aPTT), creatinine, and electrolytes—are required to identify treatable metabolic derangements (American Heart Association/American Stroke Association). 54
• Continuous cardiac monitoring should be initiated to detect atrial fibrillation or other arrhythmias that could be the embolic source (American College of Cardiology/American Heart Association). 52

Blood‑Pressure Management Strategy

Patients Not Receiving Thrombolysis

• Antihypertensive therapy should not be started or resumed when systolic BP < 220 mmHg and diastolic BP < 120 mmHg during the first 48–72 hours after stroke onset (American Heart Association/American Stroke Association). 50
• The rationale is that cerebral autoregulation is impaired in the ischemic penumbra, making cerebral blood flow directly dependent on systemic perfusion pressure; lowering BP may enlarge the infarct by reducing flow to salvageable tissue (American Heart Association/American Stroke Association). 50

Patients Receiving Intravenous Alteplase (rtPA)

• Prior to alteplase administration, BP must be lowered to < 185/110 mmHg (American Heart Association/American Stroke Association). 50
• After alteplase, BP should be maintained < 180/105 mmHg for at least 24 hours to minimize the risk of hemorrhagic transformation (American Heart Association/American Stroke Association). 50
• BP monitoring schedule after thrombolysis: every 15 minutes for the first 2 hours, then every 30 minutes for the next 6 hours, and hourly thereafter for a total of 24 hours (American College of Cardiology/American Heart Association). 52

Preferred Pharmacologic Agents for Acute BP Control

*Both agents are recommended because they allow rapid titration and avoid abrupt drops in cerebral perfusion (American College of Cardiology/American Heart Association). 52

Differential Diagnosis Considerations

• Right‑hemispheric ischemic stroke is the most likely cause of right‑hand weakness and dysarthria (American College of Cardiology/American Heart Association). 53
• Aortic dissection can present with stroke in ≈ 17 % of cases, frequently affecting the right hemisphere; urgent evaluation is warranted when hypertension and neurological deficits coexist (American College of Cardiology/American Heart Association). 53
• Stroke mimics such as seizure with Todd’s paralysis, intracranial tumor, or migrainous aura should be excluded (American Heart Association/American Stroke Association). 51

Antihypertensive Therapy Resumption (Post‑Acute Phase)

• Home antihypertensive agents should not be restarted during the first 48–72 hours unless the patient has received reperfusion therapy (American Heart Association/American Stroke Association). 50

Immediate BP‑Control Exceptions

• Acute aortic dissection requires immediate blood‑pressure reduction regardless of permissive‑hypertension recommendations (American College of Cardiology/American Heart Association). 53

Blood Pressure Management in Acute Ischemic Stroke

1. Initial 48–72 Hour Management (Patients Not Receiving Reperfusion Therapy)

• Permissive hypertension is recommended; antihypertensive drugs should not be started or restarted when systolic BP < 220 mmHg or diastolic BP < 120 mmHg during the first 48–72 h. This is a Class III (No Benefit) recommendation because treatment in this range does not reduce death or dependency and may worsen outcomes by compromising cerebral perfusion. 55
• If BP reaches ≥ 220/120 mmHg, reduce mean arterial pressure by only ≈ 15 % over the first 24 h (e.g., from ~153 mmHg to ~130 mmHg). The modest reduction balances prevention of hypertensive complications with preservation of penumbral flow. 55
• Preferred IV agents for controlled reduction:
  
  • Labetalol – 10–20 mg IV bolus over 1–2 min (repeat every 10 min, max 300 mg) or continuous infusion 2–8 mg/min; easy titration and minimal cerebral vasodilation. 55
  • Nicardipine – start 5 mg/h IV, titrate by 2.5 mg/h every 5–15 min (max 15 mg/h); useful in bradycardia or heart‑failure. 55
• Physiologic rationale: Cerebral autoregulation is markedly impaired in the ischemic penumbra, making cerebral blood flow directly dependent on systemic perfusion pressure; aggressive BP lowering can enlarge the infarct by depriving salvageable tissue. 56
• Observational data show a U‑shaped relationship between admission BP and outcomes; optimal ranges are systolic 121–200 mmHg and diastolic 81–110 mmHg. Both higher and lower pressures are linked to poorer functional outcomes. 56

2. Blood Pressure Targets When Reperfusion Therapy Is Used

a. IV Thrombolysis (Alteplase)

• Pre‑treatment BP must be lowered to < 185/110 mmHg (MAP < 135 mmHg). This is a Class I recommendation; failure to achieve the target should preclude thrombolysis. 55
• Post‑treatment BP should be maintained at < 180/105 mmHg (MAP < 130 mmHg) for at least the first 24 h to minimize the risk of symptomatic intracranial hemorrhage. 55
• Monitoring schedule: every 15 min for the first 2 h, every 30 min for the next 6 h, then hourly for the remaining 16 h. 55
• The same IV agents (labetalol or nicardipine) and dosing protocols described above are recommended for both pre‑ and post‑thrombolysis BP control. 55

b. Mechanical Thrombectomy

• Maintain BP < 185/110 mmHg before the procedure and < 180/105 mmHg for at least 24 h after the procedure, using the same pharmacologic approach as for IV thrombolysis. (Guideline‑based recommendation) 55

3. Critical Exceptions Requiring Immediate BP Reduction

• In the presence of hypertensive encephalopathy, acute aortic dissection, acute myocardial infarction, acute heart failure/pulmonary edema, post‑thrombolysis symptomatic intracranial hemorrhage, acute renal failure, or pre‑eclampsia/eclampsia, the permissive‑hypertension strategy must be overridden and BP lowered aggressively according to the specific condition’s protocol. 55

4. Transition to Long‑Term Secondary Prevention (After 48–72 h)

• Restart or initiate antihypertensive therapy in neurologically stable patients with BP ≥ 140/90 mmHg after the acute phase. This carries a Class IIa recommendation for improving long‑term BP control. 55
• For patients already on antihypertensive therapy, restarting treatment after the acute phase has Class I evidence for reducing recurrent stroke and other vascular events. 55
• Target BP for secondary prevention is < 130/80 mmHg. Meta‑analyses show that intensive lowering to this target significantly reduces recurrent stroke compared with standard targets < 140/90 mmHg, especially for preventing intracranial hemorrhage. 55
• First‑line agents (Class I): thiazide diuretics, ACE inhibitors, and angiotensin‑receptor blockers (ARBs). Combination therapy (e.g., RAS blocker + calcium‑channel blocker or thiazide) is reasonable to achieve the target, with choice individualized to comorbidities (e.g., ACE‑I/ARB preferred in diabetes with albuminuria). 55

5. Management of Hypotension

• Hypotension in acute stroke is uncommon and usually signals another underlying cause (e.g., arrhythmia, myocardial ischemia, aortic dissection, shock). Prompt evaluation and correction are required because hypotension is associated with poor neurological outcomes. 55
• Correct hypotension and hypovolemia to maintain systemic perfusion sufficient to support organ function, including the ischemic brain. 55

6. Common Pitfalls to Avoid

• Do not reflexively treat elevated BP, as it may be a compensatory mechanism preserving cerebral perfusion; rapid reduction can enlarge the infarct. 56
• Do not restart home antihypertensive medications during the first 48–72 h unless the patient is receiving reperfusion therapy or has a comorbid condition mandating immediate control. 55
• Avoid > 15 % reduction in MAP over 24 h in patients not receiving reperfusion therapy, because excessive lowering can compromise penumbral perfusion and worsen outcomes. 55

Guideline source: American Heart Association / American Stroke Association (AHA/ASA) Guidelines for the Early Management of Patients With Acute Ischemic Stroke.